Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
Vivo Ventures: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
Vivo Ventures
Vivo Ventures
Active
LinkedIn
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 1, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Jun 7, 2023
Digibee
$60.0M Series B
Natan Reinig
G2D
,
Kinea
,
Leadwind
,
Southern Europe
,
Vivo Capital
Mar 1, 2022
Klavi
$15.0M Series A
Iporanga Ventures
Bond
,
Parallax Ventures
, Eduardo Wurzmann
, Joao Otavio Oliverio
,
CIP
,
GSR Ventures
Oct 1, 2014
Aclaris Therapeutics
$21.0M Series B
—
F-Prime Capital Partners
,
Frazier Healthcare Partners
, F-Prime Capital
, Sofinnova Ventures
Apr 2, 2013
Revance Therapeutics
$104.0M Other Equity / Series E
—
Bio*One Capital
,
Delphi Ventures
,
NovaQuest Capital Management
,
Pac-Link Ventures
, Palo Alto Investors
,
Shepherd Ventures
, Technology Partners
Oct 1, 2012
Aclaris Therapeutics
$21.0M Series A
Ketan Patel
, Albert Cha
F-Prime Capital Partners
,
Frazier Healthcare Partners
, Sofinnova Ventures
Jun 1, 2012
SentreHEART
$26.0M Series C
Chen Yu
U.S. Venture Partners
,
Prospect Venture Partners
Jun 1, 2012
Ceptaris Therapeutics
$10.0M Series D
—
Frazier Healthcare Partners
,
Aperture Venture Partners
,
BioAdvance
,
Burrill & Company
,
Osage Venture Partners
, Palo Alto Investors
, Third Point
Jan 1, 2012
AirXpanders
$10.0M Series D
Albert Cha
Frazier Healthcare Partners
,
Vivo Capital
,
GBS Venture Partners
,
Heron Capital
,
Prolog Ventures
,
Western Technology Investment
Nov 16, 2011
Medley Health
$20.0M Series A
—
Thomas G. McKinley
, Jim Glasheen
, Albert Cha
Nov 1, 2011
Rempex Pharmaceuticals
$68.0M Series B
—
Frazier Healthcare Partners
,
OrbiMed
,
Adams Street Partners
, SV Health Investors
Aug 1, 2011
Ceptaris Therapeutics
$14.0M Series D
—
Frazier Healthcare Partners
,
Aperture Venture Partners
,
Burrill & Company
, Palo Alto Investors
Jun 10, 2011
Revance Therapeutics
$45.0M Other Equity
Jonathan Tunnicliffe
CNF Investments
,
Essex Capital Corporation
,
Pac-Link Ventures
, Palo Alto Investors
,
Shepherd Ventures
, Technology Partners
Jan 11, 2011
NextWave Pharmaceuticals
$45.0M Series C
Dayton Misfeldt
, Gaurav Aggarwal
Aisling Capital
, F-Prime Capital
,
Kearny Venture Partners
, Sofinnova Ventures
Jun 1, 2010
Vicept Therapeutics
$16.0M Series A
F-Prime Capital
, Sofinnova Ventures
,
Vivo Ventures
Frazier Healthcare Partners
Jan 1, 2010
Revance Therapeutics
$26.0M Series D
—
Vivo Capital
,
Bio*One Capital
,
Pac-Link Ventures
, Palo Alto Investors
,
Shepherd Ventures
, Technology Partners
Oct 23, 2008
Nora Therapeutics
$25.0M Other Equity
—
Burrill & Company
,
Prospect Venture Partners